The evidence doesn't support a link between administration of hepatitis B (HPB) vaccine and demyelinating disorders, such as multiple sclerosis (MS) and Guillain-Barré syndrome, so no change in immunization policy is warranted, according to an Institute of Medicine (IOM) report.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

No link between hepatitis B vaccine and neurologic disorders

Newsletter